渗出性糖尿病视网膜病变。使用氯贝特治疗硬渗出物，在数年内使用减少但延长的剂量[作者的翻译]。

Archives d'ophtalmologie Pub Date : 1977-01-01

P A Dorne

{"title":"渗出性糖尿病视网膜病变。使用氯贝特治疗硬渗出物，在数年内使用减少但延长的剂量[作者的翻译]。","authors":"P A Dorne","doi":"","DOIUrl":null,"url":null,"abstract":"Clofibrate is the treatment of choice in exudative diabetic retinopathy. With a low dose the exudates disappear, on the condition to carry on the treatment during several years. 1 or 2 capsules a day (500 or 1 000 mg/day) is enough. At this dose the tolerance is very good, allowing a regular and non-stop treatment.","PeriodicalId":75538,"journal":{"name":"Archives d'ophtalmologie","volume":"37 5","pages":"393-400"},"PeriodicalIF":0.0000,"publicationDate":"1977-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Exudative diabetic retinopathy. The use of clofibrate in the treatment of hard exudates using a reduced but prolonged dosage over several years (author's transl)].\",\"authors\":\"P A Dorne\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clofibrate is the treatment of choice in exudative diabetic retinopathy. With a low dose the exudates disappear, on the condition to carry on the treatment during several years. 1 or 2 capsules a day (500 or 1 000 mg/day) is enough. At this dose the tolerance is very good, allowing a regular and non-stop treatment.\",\"PeriodicalId\":75538,\"journal\":{\"name\":\"Archives d'ophtalmologie\",\"volume\":\"37 5\",\"pages\":\"393-400\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1977-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives d'ophtalmologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives d'ophtalmologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

氯贝特是渗出性糖尿病视网膜病变的首选治疗方法。低剂量时，渗出物消失，在持续治疗数年的条件下。每天1或2粒胶囊(500或1 000毫克/天)就足够了。在这个剂量下，耐受性非常好，允许定期和不间断的治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Exudative diabetic retinopathy. The use of clofibrate in the treatment of hard exudates using a reduced but prolonged dosage over several years (author's transl)].

Clofibrate is the treatment of choice in exudative diabetic retinopathy. With a low dose the exudates disappear, on the condition to carry on the treatment during several years. 1 or 2 capsules a day (500 or 1 000 mg/day) is enough. At this dose the tolerance is very good, allowing a regular and non-stop treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Archives d'ophtalmologie

自引率

0.00%

发文量